| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

From the * Spinal Unit, Neurourology, University
of Florence, Italy; and
Department of Urology,
S. Maria Annunziata Hospital, University of Florence, Italy.
| Correspondence to: Giuseppe Lombardi, Spinal Unit, Neurourology, University of Florence, Largo Palagi 1, Florence 50100, Italy (e-mail: giuseppelombardi{at}interfree.it). |
]-hydroxyprogesterone; total and free
testosterone, 17ß-estradiol, inhibin, sex hormone-binding globulin
(SHBG), and thyroid hormones (fT3 and fT4) were checked. Progesterone was
measured on the 20th to 21st day after the menstrual cycle. In patients with
amenorrhea, we tested all the hormones using 1 random blood test. After a
3-month period, the tests were repeated. Overall, 23/39 (58.9%) patients
continued to manifest at least one sexual dysfunction. These patients reached
a median score of 19.52. All but 6 patients (15.3%) consistently showed
hormonal values within the normal range. Of the 6 patients with abnormal
hormonal alterations, 5 showed at least one sexual dysfunction, 2 had low
levels of total testosterone, 1 had a low level of free testosterone, 1
suffered from hypothyroidism, 1 presented with low levels of cortisol, and 1
showed hypoprogesterone. There was no significant correlation between abnormal
hormonal status and the presence of a specific sexual dysfunction, as assessed
with the FSFI.
Key words: Spinal cord injury, blood sexual hormones, Female Sexual Function Index
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |